Category Biodiversity/Genetic Resources/Biotech

EU’s Nagoya Protocol Ratification: How It Works

The European Union Council of Ministers on 14 April adopted a decision approving the ratification of a protocol meant to facilitate access to genetic resources and to provide the fair sharing of commercial benefits with provider countries. The target date for ratification is July 2014, according to the EU.

UPOV To Examine ARIPO Legislation On Plant Variety Protection

Several committees of the International Union for the Protection of New Varieties of Plants (UPOV) will meet this week. One of them is called to assess a draft legal framework on plant variety protection from the African Regional Intellectual Property Office (ARIPO). The draft legislation has drawn ire from civil society who charge that it is detrimental to small farmers and who argue that ARIPO does not have legitimacy to become a UPOV member.

Alternative Therapies, Incentive Models Eyed For Antibiotic Resistance

As bacteria become more and more resistant to existing medicines, product pipelines are drying up. A solution may lie in a forgotten therapy developed in 1917, the use of which has been restricted to certain parts of Eastern Europe ever since the discovery and universal use of antibiotics. But business models and intellectual property regimes need to change to provide incentives for research and development in this area.

Patents Not Best To Protect Traditional Medical Knowledge, Author Says

Traditional medical knowledge would be best protected through liability rules instead of patents, according to a book exploring the applicability of intellectual property rights to traditional medical knowledge protection, and in particular if IP rights are suitable to promote the goals of the UN Convention on Biological Diversity.